Citations

Clear

3042 citation(s) found for "Kumar, S".

Mutations causing congenital myasthenia reveal principal coupling pathway in the acetylcholine receptor ε-subunit
Shen, Xin‐Ming , Brengman, Joan M., Shen, Shelley , Durmuş, Hacer , Preethish‐Kumar, Veeramani , Yüceyar, Nur , Vengalil, Seena , Deymeer, Feza , Sine, Steven M. , Engel, Andrew G. , Nalini, Atchayaram

Mayo Clinic

JCI Insight | January 24, 2018 | Volume: 3 | Issue: 2 | Pages: No page available

10.1172/jci.insight.97826 | PMID 29367459 Get It

We identify 2 homozygous mutations in the ε-subunit of the muscle acetylcholine receptor (AChR) in 3 patients with severe congenital myasthenia: εR218W in the pre-M1 region in 2 patients and εE184K in the β8-β9 linker in 1 patient. Arg218 is conserved in all eukaryotic members of the Cys-loop receptor superfamily, while Glu184 is conserved in the α-, δ-, and ε-subunits of AChRs from all species. εR218W reduces channel gating efficiency 338-fold and AChR expression on the cell surface 5-fold, whereas εE184K reduces channel gating efficiency 11-fold but does not alter AChR cell surface expression. Determinations of the effective channel gating rate constants, combined with mutant cycle analyses, demonstrate strong energetic coupling between εR218 and εE184, and between εR218 and εE45 from the β1-β2 linker, as also observed for equivalent residues in the principal coupling pathway of the α-subunit. Thus, efficient and rapid gating of the AChR channel is achieved not only by coupling between conserved residues within the principal coupling pathway of the α-subunit, but also between corresponding residues in the ε-subunit.
Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance
Kyle, Robert A. , Therneau, Terry M. , Kumar, Shaji , Larson, Dirk R. , Dispenzieri, Angela , Cerhan, James R. , Rajkumar, S. Vincent

Mayo Clinic

New England Journal of Medicine | January 17, 2018 | Volume: 378 | Issue: 3 | Pages: 241-249

10.1056/nejmoa1709974 | PMID 29342381 Get It

Lifestyle Intervention and Medical Management With vs Without Roux-en-Y Gastric Bypass and Control of Hemoglobin A 1c , LDL Cholesterol, and Systolic Blood Pressure at 5 Years in the Diabetes Surgery Study
Ikramuddin, Sayeed , Körner, Judith , Thomas, Avis J., Connett, John E. , Bantle, John P., Leslie, Daniel B. , Wang, Qi , Inabnet, William B. , Jeffery, Robert W., Chong, Keong , Chuang, Lee‐Ming , Jensen, Michael D. , Ahmed, Leaque , Belani, Kumar G. , Lee, Wei‐Jei , Vella, Adrian , Billington, Charles J.

Mayo Clinic

JAMA | January 16, 2018 | Volume: 319 | Issue: 3 | Pages: 266

10.1001/jama.2017.20813 | PMID 29340678 Get It

PI3K/AKT/mTOR pathway in multiple myeloma: from basic biology to clinical promise
Ramakrishnan, Vijay , Kumar, Shaji

Mayo Clinic

Leukemia & Lymphoma | January 11, 2018 | Volume: 59 | Issue: 11 | Pages: 2524-2534

10.1080/10428194.2017.1421760 | PMID 29322846 Get It

Glutamine-derived 2-hydroxyglutarate is associated with disease progression in plasma cell malignancies
Ramakrishnan, Vijay , Hitosugi, Taro , Ghosh, Toshi, Jevremović, Dragan , Dutta, Tumpa , Sakrikar, Dhananjay , Petterson, Xuan-Mai, Wellik, Linda, Kumar, Shaji , Jevremovic, Dragan , Gonsalves, Wilson I. , Nair, K. Sreekumaran

Mayo Clinic

JCI Insight | January 10, 2018 | Volume: 3 | Issue: 1 | Pages: No page available

10.1172/jci.insight.94543 | PMID 29321378 Get It

The production of the oncometabolite 2-hydroxyglutarate (2-HG) has been associated with c-MYC overexpression. c-MYC also regulates glutamine metabolism and drives progression of asymptomatic precursor plasma cell (PC) malignancies to symptomatic multiple myeloma (MM). However, the presence of 2-HG and its clinical significance in PC malignancies is unknown. By performing 13 C stable isotope resolved metabolomics (SIRM) using U[ 13 C 6 ]Glucose and U[ 13 C 5 ]Glutamine in human myeloma cell lines (HMCLs), we show that 2-HG is produced in clonal PCs and is derived predominantly from glutamine anaplerosis into the TCA cycle. Furthermore, the 13 C SIRM studies in HMCLs also demonstrate that glutamine is preferentially utilized by the TCA cycle compared with glucose. Finally, measuring the levels of 2-HG in the BM supernatant and peripheral blood plasma from patients with precursor PC malignancies such as smoldering MM (SMM) demonstrates that relatively elevated levels of 2-HG are associated with higher levels of c-MYC expression in the BM clonal PCs and with a subsequent shorter time to progression (TTP) to MM. Thus, measuring 2-HG levels in BM supernatant or peripheral blood plasma of SMM patients offers potential early identification of those patients at high risk of progression to MM, who could benefit from early therapeutic intervention.
Deletion of endoplasmic reticulum stress‐responsive co‐chaperone p58IPK protects mice from diet‐induced steatohepatitis
Bandla, Harikrishna, Dasgupta, Debanjali , Mauer, Amy S. , Nožičková, Barbora, Kumar, Swarup , Graham, Rondell P. , Malhi, Harmeet , Graham, Rondell P , Hirsova, Petra , Dasgupta, Debanjali

Mayo Clinic

Hepatology Research | January 10, 2018 | Volume: 48 | Issue: 6 | Pages: 479-494

10.1111/hepr.13052 | PMID 29316085 Get It

AimActivation of PKR‐like endoplasmic reticulum kinase (PERK), an endoplasmic reticulum stress sensor, is a feature of non‐alcoholic steatohepatitis (NASH), yet regulators of PERK signaling remain undefined in this context. The protein p58IPK regulates PERK; however, its role in NASH has not been examined. The aim of this study was to assess the in vivo role of p58IPK in the pathogenesis of dietary NASH.MethodsParameters of hepatocyte cell death, liver injury, inflammation, fibrosis, indirect calorimetry and PERK activation were assessed in p58IPK knockout (p58ipk−/−) mice and their wild‐type littermate controls. All animals were fed a diet enriched in fat, fructose, and cholesterol (FFC) for 20 weeks.ResultsActivation of PERK was attenuated in FFC‐fed p58ipk−/− mice. Accordingly, FFC‐fed p58ipk−/− mice showed a reduction in hepatocyte apoptosis and death receptor expression, with a significant reduction in serum alanine transaminase values. Correspondingly, macrophage accumulation and fibrosis were significantly lower in FFC‐fed p58ipk−/− mice.ConclusionWe have shown that, in an in vivo dietary NASH model, p58IPK mediates hepatocyte apoptosis and liver injury, likely through PERK phosphorylation. In the absence of p58IPK, PERK phosphorylation and NASH are attenuated. Inhibition of hepatic p58IPK could be a future target for NASH therapy.
Reply to Castillo et al.
Abeykoon, Jithma P. , King, Rebecca L. , Ansell, Stephen M., Paludo, Jonas , Kyle, Robert A. , Kumar, Shaji , Kapoor, Prashant , Paludo, Jonas , Rajkumar, S. Vincent , Gertz, Morie A.

Mayo Clinic

American Journal of Hematology | January 9, 2018 | Volume: 93 | Issue: 3 | Pages: No page available

10.1002/ajh.25029 | PMID 29314230 Get It

Prophylactic Platelet Transfusions for Critically Ill Patients With Thrombocytopenia: A Single-Institution Propensity-Matched Cohort Study
Frank, Ryan D. , Kor, Daryl J. , Warner, Matthew A. , Chandran, Arun Kumar

Mayo Clinic

Anesthesia & Analgesia | December 30, 2017 | Volume: 128 | Issue: 2 | Pages: 288-295

10.1213/ane.0000000000002794 | PMID 29293185 Get It

BACKGROUND: Thrombocytopenia is frequently encountered in critically ill patients, often resulting in prophylactic transfusion of platelets for the prevention of bleeding complications. However, the efficacy of this practice remains unclear. The objective of this study was to determine the relationship between prophylactic platelet transfusion and bleeding complications in critically ill patients. METHODS: This is a retrospective cohort study of adults admitted to surgical, medical, or combined medical-surgical intensive care units (ICUs) at a single academic institution between January 1, 2009, and December 31, 2013. Inclusion criteria included age ≥18 years and a platelet count measured during ICU admission. Propensity-matched analyses were used to evaluate associations between prophylactic platelet transfusions and the outcomes of interest with a primary outcome of red blood cell transfusion in the ensuing 24 hours and secondary outcomes of ICU and hospital-free days and changes in sequential organ failure assessment scores. RESULTS: A total of 40,693 patients were included in the investigation with 3227 (7.9%) receiving a platelet transfusion and 1065 (33.0%) for which platelet transfusion was prophylactic in nature. In propensity-matched analyses, 994 patients with prophylactic platelet transfusion were matched to those without a transfusion. Patients receiving prophylactic platelets had significantly higher red blood cell transfusion rates (odds ratio 7.5 [5.9–9.5]; P < .001), fewer ICU-free days (mean [standard deviation] 20.8 [9.1] vs 22.7 [8.3] days; P = .004), fewer hospital-free days (13.0 [9.7] vs 15.8 [9.4] days; P < .001), and less improvement in sequential organ failure assessment scores (mean decrease of 0.2 [3.6] vs 1.8 [3.3]; P < .001) in the subsequent 24 hours. These findings appeared robust, persisting in multiple predefined sensitivity analyses. CONCLUSIONS: Prophylactic administration of platelets in the critically ill was not associated with improved clinical outcomes, though residual confounding may exist. Further investigation of platelet transfusion strategies in this population is warranted.
Calcium pump epitopes in placental trophoblast basal plasma membranes
Borke, James L., Caride, Ariel J. , Kelley, Lucky K., Smith, Carl H., Penniston, John T., Kumar, Rajiv , Kumar, Rajiv , Verma, Anil Kumar

Mayo Clinic

American Journal of Physiology-Cell Physiology | December 24, 2017 | Volume: 257 | Issue: 2 | Pages: C341-C346

10.1152/ajpcell.1989.257.2.c341 | PMID 2475024 Get It

The syncytiotrophoblast represents the primary cellular barrier between maternal and fetal circulations in the placenta. Large amounts of Ca2+ are transported across this barrier by mechanisms that are not clearly understood. To further understand this phenomenon, we examined rat and human placenta by immunohistochemical and protein blotting techniques with a monoclonal antibody raised against the human erythrocyte plasma membrane Ca2+ pump. Immunohistochemistry with this antibody showed specific staining in the human placenta of the basal (fetal facing) surface of the syncytiotrophoblast. In the rat placenta, immunohistochemistry also showed specific staining of the innermost (fetal facing) layer of the trophoblast and the basal surface of the endoderm of the intraplacental yolk sac. In Western blots of placental homogenates and membranes, the monoclonal antibody bound to a 140,000-mol wt band, characteristic of Ca2+ pumps in other tissues. Western blots of isolated basal membranes showed more intense staining than isolated microvillous membranes, confirming the results of the immunohistochemistry. In addition, Ca2+ transport in basal membrane vesicles from human placenta was inhibited by polyclonal antibodies prepared against the erythrocyte Ca2+ pump. We conclude that basal (fetal facing) layers of human and rat placentas contain a high-affinity Ca2+ pump situated to transport Ca2+ from the maternal to the fetal circulation. calcium-magnesium-adenosinetriphosphatase; calcium transport; immunohistochemistry; rat and human placenta Submitted on November 14, 1988 Accepted on March 27, 1989
Regulation of Cellular Growth by 1,25-Dihydroxyvitamin D3-Mediated Growth Factor Expression
Veenstra, Timothy D. , Pittelkow, Mark R. , Kumar, Rajiv , Kumar, Rajiv

Mayo Clinic

Physiology | December 24, 2017 | Volume: 14 | Issue: 1 | Pages: 37-40

10.1152/physiologyonline.1999.14.1.37 | PMID 11390816 Get It

Although the primary function of 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] is the regulation of calcium and phosphorus metabolism, it also regulates the growth and differentiation of several different cell types. Recent work suggests that 1,25(OH)2D3 regulates cellular growth by altering the synthesis of growth factors and growth factor responses.